CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,870,145 | -18.9% | 368,183 | -14.2% | 0.11% | -21.4% |
| Q3 2022 | $20,798,000 | +11.3% | 429,273 | -9.7% | 0.14% | +22.9% |
| Q2 2022 | $18,683,000 | -56.3% | 475,525 | -59.0% | 0.12% | -43.8% |
| Q1 2022 | $42,731,000 | -57.1% | 1,160,845 | -46.8% | 0.21% | -48.3% |
| Q4 2021 | $99,513,000 | +5.1% | 2,183,250 | -17.6% | 0.41% | +5.5% |
| Q3 2021 | $94,641,000 | +84.3% | 2,648,037 | +2.1% | 0.38% | +85.1% |
| Q2 2021 | $51,341,000 | -15.4% | 2,594,312 | -0.6% | 0.21% | -23.8% |
| Q1 2021 | $60,703,000 | +14.3% | 2,609,751 | +2.1% | 0.27% | +4.6% |
| Q4 2020 | $53,108,000 | -19.4% | 2,555,740 | -16.1% | 0.26% | -37.7% |
| Q3 2020 | $65,913,000 | -2.3% | 3,044,470 | +6.3% | 0.42% | -14.1% |
| Q2 2020 | $67,478,000 | +90.8% | 2,862,891 | -4.6% | 0.49% | +32.6% |
| Q1 2020 | $35,369,000 | +28.5% | 2,999,913 | +15.7% | 0.37% | +62.8% |
| Q4 2019 | $27,517,000 | -1.8% | 2,593,460 | +5.4% | 0.23% | -15.4% |
| Q3 2019 | $28,012,000 | -22.6% | 2,461,526 | -23.5% | 0.27% | -24.4% |
| Q2 2019 | $36,190,000 | +40.3% | 3,216,872 | +0.9% | 0.35% | +25.6% |
| Q1 2019 | $25,795,000 | +66.1% | 3,188,487 | +29.8% | 0.28% | +35.7% |
| Q4 2018 | $15,527,000 | -16.7% | 2,456,805 | +29.8% | 0.21% | -2.8% |
| Q3 2018 | $18,642,000 | +22.7% | 1,892,592 | +3.4% | 0.21% | +16.4% |
| Q2 2018 | $15,189,000 | +19.7% | 1,830,049 | +3.9% | 0.18% | +11.6% |
| Q1 2018 | $12,686,000 | -7.3% | 1,761,882 | +4.9% | 0.16% | -9.9% |
| Q4 2017 | $13,690,000 | +34.4% | 1,679,778 | +139.1% | 0.18% | +31.9% |
| Q3 2017 | $10,189,000 | +9.5% | 702,672 | -8.6% | 0.14% | +6.2% |
| Q2 2017 | $9,307,000 | -51.5% | 769,190 | -48.5% | 0.13% | -54.1% |
| Q1 2017 | $19,181,000 | -5.6% | 1,492,698 | -10.7% | 0.28% | -7.8% |
| Q4 2016 | $20,310,000 | +28.4% | 1,671,615 | -3.0% | 0.31% | +30.1% |
| Q3 2016 | $15,819,000 | -4.5% | 1,723,160 | -1.3% | 0.24% | -7.1% |
| Q2 2016 | $16,570,000 | +413.8% | 1,746,096 | +264.3% | 0.25% | +418.4% |
| Q1 2016 | $3,225,000 | -35.6% | 479,242 | +0.1% | 0.05% | -29.0% |
| Q4 2015 | $5,009,000 | +36.7% | 478,890 | -12.6% | 0.07% | +40.8% |
| Q3 2015 | $3,665,000 | -0.4% | 547,779 | 0.0% | 0.05% | +22.5% |
| Q2 2015 | $3,681,000 | -1.1% | 547,779 | -0.2% | 0.04% | +2.6% |
| Q1 2015 | $3,722,000 | -25.2% | 549,030 | -11.6% | 0.04% | -25.0% |
| Q4 2014 | $4,976,000 | +115.8% | 621,164 | -5.2% | 0.05% | +116.7% |
| Q3 2014 | $2,306,000 | +178.5% | 655,081 | +278.3% | 0.02% | +200.0% |
| Q2 2014 | $828,000 | -41.4% | 173,176 | +16.3% | 0.01% | -42.9% |
| Q1 2014 | $1,414,000 | -14.1% | 148,872 | -41.2% | 0.01% | -12.5% |
| Q4 2013 | $1,646,000 | +44.1% | 253,203 | +68.3% | 0.02% | +33.3% |
| Q3 2013 | $1,142,000 | – | 150,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |